Covered recipient · General Payments record
NASSER MIZBAN
General Payments · PY2019–2024
$830.21
- Reported across 36 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $276.28 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $61.58 | 2 |
| Medtronic, Inc. | $57.25 | 2 |
| ABBVIE INC. | $44.07 | 3 |
| Amgen Inc. | $30.22 | 1 |
| Sandoz Inc. | $25.28 | 1 |
| DEXCOM, INC. | $24.18 | 1 |
| Averitas Pharma Inc. | $20.55 | 1 |
| Lilly USA, LLC | $13.15 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.55 | 05/28/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1105048014 | CMS |
| ABBVIE INC. | $14.24 | 07/10/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1105048016 | CMS |
| ABBVIE INC. | $15.28 | 10/14/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1105048018 | CMS |
| Amgen Inc. | $30.22 | 04/30/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1115936980 | CMS |
| Averitas Pharma Inc. | $20.55 | 08/04/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1133437286 | CMS |
| Dexcom, Inc. | $24.18 | 10/08/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1153324815 | CMS |
| Janssen Biotech, Inc. | $33.98 | 04/02/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1078309032 | CMS |
| Janssen Biotech, Inc. | $27.60 | 06/04/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1078306254 | CMS |
| Lilly USA, LLC | $13.15 | 06/19/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1135218891 | CMS |
| Medtronic, Inc. | $26.20 | 01/18/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1246928858 | CMS |
| Medtronic, Inc. | $31.05 | 10/31/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1246928862 | CMS |
| Sandoz Inc. | $25.28 | 03/12/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1089365843 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.